血清镁、骨矿物质代谢标志物及其与肾功能的交互作用对后续外周动脉疾病风险的影响
在ARIC研究11 839名基线无PAD的参与者中,中位随访23年发生471例外周动脉疾病。血清镁最低四分位(<1.5 mEq/L)较最高四分位(>1.7 mEq/L)的PAD风险显著升高(HR 1.96,95%CI 1.40-2.74),该关联在eGFR≥60者中明显,在eGFR<60者中减弱(交互P=0.03);iPTH>65 pg/mL仅在eGFR<60者中与PAD相关。
要点
- 低血清镁(<1.5 mEq/L)与PAD风险独立相关,但此关联在eGFR<60者中显著减弱。
- iPTH>65 pg/mL仅在eGFR<60 mL/min/1.73 m2者中与PAD风险显著相关。
- 肾功能可能修饰镁及iPTH与外周动脉疾病的关系。
核心结论
- 较低血清镁与偶发PAD独立相关,但在肾功能减退者中该关联显著减弱。
- 较高iPTH水平在eGFR<60 mL/min/1.73 m2人群中尤其与PAD风险相关。
研究设计与样本
- 前瞻性队列研究,纳入ARIC研究Visit 2(1990-92)时无PAD的11 839名参与者。
- 采用多变量Cox比例风险回归分析血清镁及其他骨矿物质代谢标志物与偶发PAD的关联。
主要发现
- 中位随访23年,共发生471例偶发PAD。
- 镁最低四分位(<1.5 mEq/L)对比最高四分位(>1.7 mEq/L)的PAD风险HR为1.96(95%CI 1.40-2.74),已调整潜在混杂因素。
- 低镁与PAD的关联在eGFR≥60 mL/min/1.73 m2者(n=11 606)中更明显,在eGFR<60 mL/min/1.73 m2者(n=233)中基本平坦,交互P=0.03。
- 骨矿物质代谢标志物中,仅较高iPTH与肾功能存在交互作用(交互P=0.01)。
- iPTH>65 pg/mL仅在eGFR<60 mL/min/1.73 m2者中与PAD显著相关。
临床怎么用
- 在肾功能正常或轻度下降人群中,低血清镁可能提示PAD风险增加,可结合临床评估。
- 在eGFR<60 mL/min/1.73 m2人群中,iPTH>65 pg/mL与PAD风险相关,监测iPTH可能有助风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few studies have investigated the association of magnesium levels with incident peripheral artery disease (PAD) despite emerging evidence of magnesium contributing to vascular calcification. Moreover, no data are available on whether the magnesium-PAD relationship is independent of or modified by kidney function. METHODS: A cohort of 11 839 participants free of PAD in the Atherosclerosis Risk in Communities Study at Visit 2 (1990-92) was studied. We investigated the association of serum magnesium and other bone-mineral metabolism markers [calcium, phosphorus, intact parathyroid hormone (iPTH) and intact fibroblast growth factor-23] with incident PAD using multivariable Cox proportional hazards regression. RESULTS: Over a median of 23 years, there were 471 cases of incident PAD. The hazard ratio for incident PAD in Quartile 1 (<1.5 mEq/L) versus Quartile 4 (>1.7 mEq/L) of magnesium was 1.96 (95% confidence interval 1.40-2.74) after adjustment for potential confounders. Lower magnesium levels were associated with greater incidence of PAD, particularly in those with estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2 (n = 11 606). In contrast, the association was largely flat in those with eGFR <60 mL/min/1.73 m2 (n = 233) with P-for-interaction 0.03. Among bone-mineral metabolism markers, only higher iPTH showed an interaction with kidney function (P-for-interaction 0.01) and iPTH >65 pg/mL was significantly related to PAD only in those with eGFR <60 mL/min/1.73 m2. CONCLUSIONS: Lower magnesium was independently associated with incident PAD, but this association was significantly weaker in those with reduced kidney function. In contrast, higher iPTH levels were particularly related to PAD risk in this clinical population.
引用
- Menez S, Ding N, Grams ME, et al. Serum magnesium, bone-mineral metabolism markers and their interactions with kidney function on subsequent risk of peripheral artery disease: the Atherosclerosis Risk in Communities Study. Nephrol Dial Transplant. 2020. PMID: 32191294. doi:10.1093/ndt/gfaa029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。